# Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease

> **NCT01595750** · PHASE4 · UNKNOWN · sponsor: **Spanish Research Center for Respiratory Diseases** · enrollment: 150 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Roflumilast 500
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01595750
- **Lead sponsor:** Spanish Research Center for Respiratory Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2012-07
- **Final completion:** 2012-08
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2012-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01595750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01595750, "Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01595750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*